SLS — SELLAS Life Sciences Group, Inc. | XLV Holdings | StockAdder

(SLS)

SELLAS Life Sciences Group, Inc.

Live chart and latest SLS stock news.

Sector ETF → XLV Health Care Select

Chart powered byTradingView— professional charts for every trader.Try it free →

SLS News

SELLAS Life Sciences Group Inc. (SLS) Making Progress on Key Acute Myeloid Leukemia Treatment

Apr 14, 2026 ChartMill

SLS News | SELLAS LIFE SCIENCES GROUP I (NASDAQ:SLS)

Apr 10, 2026 simplywall.st

Why SELLAS Life Sciences Group (SLS) Is Down 8.3% After US$150 Million ATM Offering News

Mar 30, 2026 Stock Titan

SELLAS nears key leukemia trial readout after raising $42.6M in Q1

Mar 19, 2026 MSN

SELLAS Life Sciences (SLS) to present SLS009 data at AACR 2026

Apr 13, 2026 Insider Monkey

SELLAS Life Sciences Group Inc. (SLS) Making Progress on Key Acute Myeloid Leukemia Treatment

Apr 14, 2026 24/7 Wall St.

SELLAS Stock Up 346% in a Year as Cancer Vaccine Trial Nears Its Final 8 Deaths

Mar 20, 2026 Quiver Quantitative

SELLAS Life Sciences Group Stock (SLS) Opinions on Phase 3 Trial Progress

Jan 2, 2026 Yahoo Finance

All You Need to Know About SELLAS Life Sciences Group, Inc. (SLS) Rating Upgrade to Buy

Mar 26, 2026 simplywall.st

A Look At SELLAS Life Sciences Group (SLS) Valuation After SLS009 Data And New Equity Offering Plans

Mar 28, 2026 Quiver Quantitative

SELLAS Life Sciences Group Stock (SLS) Opinions on Phase 3 REGAL Trial Progress | SLS Stock News

Jan 13, 2026 Yahoo Finance

Assessing SELLAS Life Sciences Group (SLS) Valuation After Its Sharp Recent Share Price Run

Mar 22, 2026 Yahoo Finance

Wall Street Analysts Believe SELLAS Life Sciences Group, Inc. (SLS) Could Rally 63.58%: Here's is How to Trade

Mar 26, 2026 Yahoo Finance

Assessing SELLAS Life Sciences Group (SLS) Valuation After Recent Leukemia Trial Updates

Mar 7, 2026 Yahoo Finance

Assessing SELLAS Life Sciences Group (SLS) Valuation After Positive Leukemia Data and Supportive FDA Designations